Eagle Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$16.5M Sell
50,670
-22,420
-31% -$7.33M 0.08% 215
2024
Q2
$22.7M Buy
73,090
+1,312
+2% +$385K 0.12% 165
2024
Q1
$20.3M Sell
71,778
-412,053
-85% -$121M 0.1% 191
2023
Q4
$139M Buy
483,831
+126,503
+35% +$34.5M 0.75% 34
2023
Q3
$96M Buy
357,328
+309,234
+643% +$77.2M 0.57% 65
2023
Q2
$10.7M Buy
48,094
+482
+1% +$112K 0.06% 252
2023
Q1
$11.5M Buy
47,612
+711
+2% +$175K 0.07% 229
2022
Q4
$12.3M Buy
46,901
+102
+0.2% +$27.3K 0.08% 213
2022
Q3
$10.5M Hold
46,799
0.07% 234
2022
Q2
$11.4M Hold
46,799
0.07% 227
2022
Q1
$11.3M Sell
46,799
-256
-0.5% -$58.8K 0.06% 256
2021
Q4
$10.7M Buy
47,055
+250
+0.5% +$52.8K 0.05% 300
2021
Q3
$9.95M Buy
46,805
+58
+0.1% +$13.3K 0.04% 318
2021
Q2
$11.4M Sell
46,747
-11,687
-20% -$2.88M 0.05% 297
2021
Q1
$14.6M Buy
58,434
+7,733
+15% +$1.85M 0.06% 267
2020
Q4
$11.7M Sell
50,701
-360,413
-88% -$83.1M 0.07% 268
2020
Q3
$102M Buy
411,114
+248,377
+153% +$61.5M 0.53% 66
2020
Q2
$37.7M Buy
162,737
+18,275
+13% +$4.17M 0.21% 160
2020
Q1
$29.3M Buy
144,462
+119,755
+485% +$26.2M 0.18% 179
2019
Q4
$5.96M Buy
24,707
+6,029
+32% +$1.33M 0.03% 383
2019
Q3
$3.61M Buy
18,678
+911
+5% +$175K 0.02% 456
2019
Q2
$3.27M Buy
17,767
+819
+5% +$147K 0.02% 450
2019
Q1
$3.22M Sell
16,948
-12,956
-43% -$2.47M 0.02% 462
2018
Q4
$5.82M Sell
29,904
-504
-2% -$98.3K 0.04% 361
2018
Q3
$6.3M Buy
30,408
+746
+3% +$147K 0.03% 410
2018
Q2
$5.47M Buy
29,662
+493
+2% +$87.2K 0.03% 412
2018
Q1
$4.97M Buy
29,169
+97
+0.3% +$17.8K 0.03% 422
2017
Q4
$5.13M Sell
29,072
-48
-0.2% -$8.49K 0.03% 424
2017
Q3
$5.45M Sell
29,120
-219
-0.7% -$38.8K 0.03% 424
2017
Q2
$5.05M Sell
29,339
-80
-0.3% -$13K 0.03% 425
2017
Q1
$4.83M Buy
29,419
+265
+0.9% +$44K 0.03% 428
2016
Q4
$4.26M Buy
29,154
+1,294
+5% +$195K 0.03% 431
2016
Q3
$4.65M Sell
27,860
-1,175
-4% -$199K 0.03% 418
2016
Q2
$4.42M Sell
29,035
-438
-1% -$68.1K 0.03% 433
2016
Q1
$4.42M Buy
29,473
+66
+0.2% +$9.8K 0.03% 423
2015
Q4
$4.77M Sell
29,407
-499
-2% -$78.4K 0.03% 414
2015
Q3
$4.14M Sell
29,906
-2,738
-8% -$432K 0.03% 444
2015
Q2
$5.01M Sell
32,644
-376
-1% -$60.2K 0.03% 429
2015
Q1
$5.28M Sell
33,020
-363
-1% -$57.2K 0.03% 416
2014
Q4
$5.32M Sell
33,383
-16,879
-34% -$2.63M 0.03% 412
2014
Q3
$7.06M Sell
50,262
-3,136
-6% -$409K 0.04% 381
2014
Q2
$6.32M Sell
53,398
-16,579
-24% -$1.92M 0.03% 413
2014
Q1
$8.63M Sell
69,977
-876
-1% -$106K 0.05% 373
2013
Q4
$8.08M Sell
70,853
-73,063
-51% -$8.31M 0.05% 341
2013
Q3
$16.3M Buy
143,916
+70,157
+95% +$7.61M 0.08% 289
2013
Q2
$7.28M Buy
+73,759
New +$7.65M 0.05% 399

Other funds holding AMGN

Eagle Asset Management's AMGN Position: Q3 2024 in Review

Eagle Asset Management reduced its Amgen (AMGN) stake by 31% in Q3 2024, selling an estimated $7.33M and leaving 50,670 shares worth $16.5M. The position accounts for 0.08% of the portfolio, ranked #215.

Eagle Asset Management first reported a position in AMGN in Q2 2013 and has held it in 46 quarters since. The position peaked at $139M in Q4 2023. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Eagle Asset Management held 50,670 shares of Amgen worth $16.5M as of Q3 2024.
  • Eagle Asset Management sold 22,420 Amgen shares in Q3 2024, an estimated $7.33M.
  • Amgen made up 0.08% of Eagle Asset Management's portfolio in Q3 2024, its #215 holding.
  • Eagle Asset Management first reported a position in Amgen in Q2 2013 and has held it in 46 quarters since.
  • Eagle Asset Management's Amgen position peaked at $139M in Q4 2023.
  • 2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.